Renegade Bio
Berkeley, United States · Founded 2020 · $330K raised
- Headquarters
- Berkeley
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- renegade.bio
- Total Funding
- $330K
- Last Round
- $330K Series AMar 2023
- Rounds
- 2
About
Renegade Bio was a Berkeley, California-based public benefit corporation providing COVID-19 diagnostic testing services for businesses, schools, and communities. Founded in 2020 by Craig Rouskey, it operated its own CLIA- and CAP-certified lab and developed novel diagnostics leveraging PCR, NGS, and LCMS capabilities. The company closed in March 2024 after four years of operation.
Summary
Renegade Bio is a Biotech company based in Berkeley, United States, founded in 2020. It has raised $330K in total across 2 rounds, most recently a $330K Series A round in Mar 2023. Investors include Anzu Partners, FinRebel and SOSV.
Funding History
Mar 2023
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/renegade-bio"><img src="https://indexed.vc/api/badge/company/renegade-bio" alt="Renegade Bio on Indexed.vc" width="260" height="76" /></a>